Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Mazdutide

PRIME

Innovent · Phase 4 · Recruiting · Enrollment 60

NCT07718126

ArmPopulationDoseWeeksEstimandWeight change
GLP-1/GCG receptor dual agonist plus lifestyle optimization (GG Group)Metabolic Dysfunction-Associated Steatohepati...n/r1n/rn/r
Lifestyle optimization only (LL group)Metabolic Dysfunction-Associated Steatohepati...n/r1n/rn/r